17-alpha-Hydroxyprogesterone
The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Cholestyramine.
Aceclofenac
Cholestyramine can cause a decrease in the absorption of Aceclofenac resulting in a reduced serum concentration and potentially a decrease in efficacy.
Acemetacin
Cholestyramine can cause a decrease in the absorption of Acemetacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
Acenocoumarol
Cholestyramine can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Acetaminophen
Cholestyramine can cause a decrease in the absorption of Acetaminophen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Acetyl salicylate
Cholestyramine can cause a decrease in the absorption of Acetylsalicylic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
Acetyldigitoxin
Cholestyramine can cause a decrease in the absorption of Acetyldigitoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Adapalene
Cholestyramine can cause a decrease in the absorption of Adapalene resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alclometasone
Cholestyramine can cause a decrease in the absorption of Alclometasone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
Aldosterone
Cholestyramine can cause a decrease in the absorption of Aldosterone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alfacalcidol
The serum concentration of Alfacalcidol can be decreased when it is combined with Cholestyramine.
Alminoprofen
Cholestyramine can cause a decrease in the absorption of Alminoprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Amcinonide
Cholestyramine can cause a decrease in the absorption of Amcinonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Amiodarone
The serum concentration of Amiodarone can be decreased when it is combined with Cholestyramine.
Androstenedione
Cholestyramine can cause a decrease in the absorption of Androstenedione resulting in a reduced serum concentration and potentially a decrease in efficacy.
Antipyrine
Cholestyramine can cause a decrease in the absorption of Antipyrine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Apazone
Cholestyramine can cause a decrease in the absorption of Azapropazone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Apremilast
Cholestyramine can cause a decrease in the absorption of Apremilast resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aspirin
Cholestyramine can cause a decrease in the absorption of Acetylsalicylic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Atorvastatin
Cholestyramine can cause a decrease in the absorption of Atorvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Azelastine
Cholestyramine can cause a decrease in the absorption of Azelastine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Azosemide
Cholestyramine can cause a decrease in the absorption of Azosemide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Balsalazide
Cholestyramine can cause a decrease in the absorption of Balsalazide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Beclomethasone Dipropionate
Cholestyramine can cause a decrease in the absorption of Beclomethasone dipropionate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bendroflumethiazide
Cholestyramine can cause a decrease in the absorption of Bendroflumethiazide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Benzthiazide
Cholestyramine can cause a decrease in the absorption of Benzthiazide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Benzydamine
Cholestyramine can cause a decrease in the absorption of Benzydamine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Betamethasone
Cholestyramine can cause a decrease in the absorption of Betamethasone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bezafibrate
Cholestyramine can cause a decrease in the absorption of Bezafibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bromfenac
Cholestyramine can cause a decrease in the absorption of Bromfenac resulting in a reduced serum concentration and potentially a decrease in efficacy.
Budesonide
Cholestyramine can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bufexamac
Cholestyramine can cause a decrease in the absorption of Bufexamac resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bumetanide
Cholestyramine can cause a decrease in the absorption of Bumetanide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcifediol
The serum concentration of Calcidiol can be decreased when it is combined with Cholestyramine.
Calcifediol Anhydrous
The serum concentration of Calcidiol can be decreased when it is combined with Cholestyramine.
Calcipotriene
The serum concentration of Calcipotriol can be decreased when it is combined with Cholestyramine.
Calcitriol
The serum concentration of Calcitriol can be decreased when it is combined with Cholestyramine.
Carprofen
Cholestyramine can cause a decrease in the absorption of Carprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Celecoxib
Cholestyramine can cause a decrease in the absorption of Celecoxib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cerivastatin
Cholestyramine can cause a decrease in the absorption of Cerivastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Chenodeoxycholate
The serum concentration of Chenodeoxycholic acid can be decreased when it is combined with Cholestyramine.
Chenodeoxycholic Acid
The serum concentration of Chenodeoxycholic acid can be decreased when it is combined with Cholestyramine.
Chloroquine
Cholestyramine can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Chlorothiazide
Cholestyramine can cause a decrease in the absorption of Chlorothiazide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Chlortetracycline
Cholestyramine can cause a decrease in the absorption of Chlortetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Chlorthalidone
Cholestyramine can cause a decrease in the absorption of Chlorthalidone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cholecalciferol
The serum concentration of Cholecalciferol can be decreased when it is combined with Cholestyramine.
Cholic Acid
Cholestyramine can cause a decrease in the absorption of Cholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
Cholestyramine can cause a decrease in the absorption of Choline magnesium trisalicylate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ciclesonide
Cholestyramine can cause a decrease in the absorption of Ciclesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ciprofibrate
Cholestyramine can cause a decrease in the absorption of Ciprofibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Clobetasol
Cholestyramine can cause a decrease in the absorption of Clobetasol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Clobetasol Propionate
Cholestyramine can cause a decrease in the absorption of Clobetasol propionate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Clobetasone
Cholestyramine can cause a decrease in the absorption of Clobetasone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Clocortolone
Cholestyramine can cause a decrease in the absorption of Clocortolone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Clofibrate
Cholestyramine can cause a decrease in the absorption of Clofibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Clonixin
Cholestyramine can cause a decrease in the absorption of Clonixin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cortisone Acetate
Cholestyramine can cause a decrease in the absorption of Cortisone acetate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Curcumin
Cholestyramine can cause a decrease in the absorption of Curcumin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cyclopenthiazide
Cholestyramine can cause a decrease in the absorption of Cyclopenthiazide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cyproterone Acetate
The serum concentration of Cyproterone acetate can be decreased when it is combined with Cholestyramine.
Deferasirox
The serum concentration of Deferasirox can be decreased when it is combined with Cholestyramine.
Deflazacort
Cholestyramine can cause a decrease in the absorption of Deflazacort resulting in a reduced serum concentration and potentially a decrease in efficacy.
Demeclocycline
Cholestyramine can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deslanoside
Cholestyramine can cause a decrease in the absorption of Deslanoside resulting in a reduced serum concentration and potentially a decrease in efficacy.
Desogestrel
The serum concentration of Desogestrel can be decreased when it is combined with Cholestyramine.
Desonide
Cholestyramine can cause a decrease in the absorption of Desonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Desoximetasone
Cholestyramine can cause a decrease in the absorption of Desoximetasone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Desoxycorticosterone acetate
Cholestyramine can cause a decrease in the absorption of Desoxycorticosterone acetate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Desoxycorticosterone Pivalate
Cholestyramine can cause a decrease in the absorption of Desoxycorticosterone Pivalate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dexamethasone
Cholestyramine can cause a decrease in the absorption of Dexamethasone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Diclofenac
Cholestyramine can cause a decrease in the absorption of Diclofenac resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dicumarol
Cholestyramine can cause a decrease in the absorption of Dicoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dienogest
The serum concentration of Dienogest can be decreased when it is combined with Cholestyramine.
Diethylstilbestrol
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Cholestyramine.
Diflorasone
Cholestyramine can cause a decrease in the absorption of Diflorasone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Diflucortolone
Cholestyramine can cause a decrease in the absorption of Difluocortolone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Diflunisal
Cholestyramine can cause a decrease in the absorption of Diflunisal resulting in a reduced serum concentration and potentially a decrease in efficacy.
Difluprednate
Cholestyramine can cause a decrease in the absorption of Difluprednate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Digitoxin
Cholestyramine can cause a decrease in the absorption of Digitoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Digoxin
Cholestyramine can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dihydrotachysterol
The serum concentration of Dihydrotachysterol can be decreased when it is combined with Cholestyramine.
Dipyrone
Cholestyramine can cause a decrease in the absorption of Metamizole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Doxercalciferol
The serum concentration of Doxercalciferol can be decreased when it is combined with Cholestyramine.
Doxycycline
Cholestyramine can cause a decrease in the absorption of Doxycycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Doxycycline Anhydrous
Cholestyramine can cause a decrease in the absorption of Doxycycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Drospirenone
The serum concentration of Drospirenone can be decreased when it is combined with Cholestyramine.
Droxicam
Cholestyramine can cause a decrease in the absorption of Droxicam resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ergocalciferol
The serum concentration of Ergocalciferol can be decreased when it is combined with Cholestyramine.
Estradiol
The serum concentration of Estradiol can be decreased when it is combined with Cholestyramine.
Estradiol Cypionate
The serum concentration of Estradiol cypionate can be decreased when it is combined with Cholestyramine.
Estradiol Valerate
The serum concentration of Estradiol valerate can be decreased when it is combined with Cholestyramine.
Estrone
Cholestyramine can cause a decrease in the absorption of Estrone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Etanercept
Cholestyramine can cause a decrease in the absorption of Etanercept resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ethacrynate
Cholestyramine can cause a decrease in the absorption of Etacrynic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ethacrynic Acid
Cholestyramine can cause a decrease in the absorption of Etacrynic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ethinyl Estradiol
The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Cholestyramine.
Ethynodiol Diacetate
The serum concentration of Ethynodiol diacetate can be decreased when it is combined with Cholestyramine.
Etodolac
Cholestyramine can cause a decrease in the absorption of Etodolac resulting in a reduced serum concentration and potentially a decrease in efficacy.
Etofenamate
Cholestyramine can cause a decrease in the absorption of Etofenamate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Etofibrate
Cholestyramine can cause a decrease in the absorption of Etofibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Etonogestrel
The serum concentration of Etonogestrel can be decreased when it is combined with Cholestyramine.
Etoricoxib
Cholestyramine can cause a decrease in the absorption of Etoricoxib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Evening primrose oil
Cholestyramine can cause a decrease in the absorption of Evening primrose oil resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ezetimibe
Cholestyramine can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially a decrease in efficacy.
Felbinac
Cholestyramine can cause a decrease in the absorption of Felbinac resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fenbufen
Cholestyramine can cause a decrease in the absorption of Fenbufen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fenofibrate
Cholestyramine can cause a decrease in the absorption of Fenofibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fenofibric Acid
Cholestyramine can cause a decrease in the absorption of Fenofibric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fenoprofen
Cholestyramine can cause a decrease in the absorption of Fenoprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferulic Acid
Cholestyramine can cause a decrease in the absorption of Ferulic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Floctafenine
Cholestyramine can cause a decrease in the absorption of Floctafenine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fludrocortisone
Cholestyramine can cause a decrease in the absorption of Fludrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fluindione
Cholestyramine can cause a decrease in the absorption of Fluindione resulting in a reduced serum concentration and potentially a decrease in efficacy.
Flumethasone
Cholestyramine can cause a decrease in the absorption of Flumethasone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Flunisolide
Cholestyramine can cause a decrease in the absorption of Flunisolide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Flunisolide Anhydrous (obsolete)
Cholestyramine can cause a decrease in the absorption of Flunisolide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fluocinolone Acetonide
Cholestyramine can cause a decrease in the absorption of Fluocinolone Acetonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fluocinonide
Cholestyramine can cause a decrease in the absorption of Fluocinonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fluocortolone
Cholestyramine can cause a decrease in the absorption of Fluocortolone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fluorometholone
Cholestyramine can cause a decrease in the absorption of Fluorometholone resulting in a reduced serum concentration and potentially a decrease in efficacy.
FLUPREDNIDENE
Cholestyramine can cause a decrease in the absorption of Fluprednidene resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fluprednisolone
Cholestyramine can cause a decrease in the absorption of Fluprednisolone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Flurandrenolide
Cholestyramine can cause a decrease in the absorption of Flurandrenolide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Flurbiprofen
Cholestyramine can cause a decrease in the absorption of Flurbiprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fluticasone
Cholestyramine can cause a decrease in the absorption of Fluticasone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fluticasone Furoate
Cholestyramine can cause a decrease in the absorption of Fluticasone furoate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fluticasone propionate
Cholestyramine can cause a decrease in the absorption of Fluticasone propionate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fluvastatin
The serum concentration of Fluvastatin can be decreased when it is combined with Cholestyramine.
Formestane
Cholestyramine can cause a decrease in the absorption of Formestane resulting in a reduced serum concentration and potentially a decrease in efficacy.
Furosemide
Cholestyramine can cause a decrease in the absorption of Furosemide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Gemfibrozil
Cholestyramine can cause a decrease in the absorption of Gemfibrozil resulting in a reduced serum concentration and potentially a decrease in efficacy.
Gestodene
The serum concentration of Gestodene can be decreased when it is combined with Cholestyramine.
Gestrinone
The serum concentration of Gestrinone can be decreased when it is combined with Cholestyramine.
Halcinonide
Cholestyramine can cause a decrease in the absorption of Halcinonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Halobetasol
Cholestyramine can cause a decrease in the absorption of Ulobetasol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Hydrochlorothiazide
Cholestyramine can cause a decrease in the absorption of Hydrochlorothiazide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Hydrocortisone
Cholestyramine can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Hydroflumethiazide
Cholestyramine can cause a decrease in the absorption of Hydroflumethiazide resulting in a reduced serum concentration and potentially a decrease in efficacy.
hydroxyprogesterone caproate (USP)
The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Cholestyramine.
Ibuprofen
Cholestyramine can cause a decrease in the absorption of Ibuprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Icatibant
Cholestyramine can cause a decrease in the absorption of Icatibant resulting in a reduced serum concentration and potentially a decrease in efficacy.
Indapamide
Cholestyramine can cause a decrease in the absorption of Indapamide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Indobufen
Cholestyramine can cause a decrease in the absorption of Indobufen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Indomethacin
Cholestyramine can cause a decrease in the absorption of Indomethacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Kebuzone
Cholestyramine can cause a decrease in the absorption of Kebuzone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ketoprofen
Cholestyramine can cause a decrease in the absorption of Ketoprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ketorolac
Cholestyramine can cause a decrease in the absorption of Ketorolac resulting in a reduced serum concentration and potentially a decrease in efficacy.
Leflunomide
The serum concentration of the active metabolites of Leflunomide can be reduced when Leflunomide is used in combination with Cholestyramine resulting in a loss in efficacy.
Levomefolate
The serum concentration of Levomefolic acid can be decreased when it is combined with Cholestyramine.
Levomefolic Acid
The serum concentration of Levomefolic acid can be decreased when it is combined with Cholestyramine.
Levonorgestrel
The serum concentration of Levonorgestrel can be decreased when it is combined with Cholestyramine.
Levothyroxine
The serum concentration of Levothyroxine can be decreased when it is combined with Cholestyramine.
Limonene, (+)-
Cholestyramine can cause a decrease in the absorption of (4R)-limonene resulting in a reduced serum concentration and potentially a decrease in efficacy.
Liothyronine
The serum concentration of Liothyronine can be decreased when it is combined with Cholestyramine.
Lipegfilgrastim
Cholestyramine may increase the myelosuppressive activities of Lipegfilgrastim.
Lomitapide
Cholestyramine can cause a decrease in the absorption of Lomitapide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Lornoxicam
Cholestyramine can cause a decrease in the absorption of Lornoxicam resulting in a reduced serum concentration and potentially a decrease in efficacy.
Loteprednol
Cholestyramine can cause a decrease in the absorption of Loteprednol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Lovastatin
Cholestyramine can cause a decrease in the absorption of Lovastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Loxoprofen
Cholestyramine can cause a decrease in the absorption of Loxoprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Lynestrenol
The serum concentration of Lynestrenol can be decreased when it is combined with Cholestyramine.
Magnesium Salicylate
Cholestyramine can cause a decrease in the absorption of Magnesium salicylate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Masoprocol
Cholestyramine can cause a decrease in the absorption of Masoprocol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Meclofenamate
Cholestyramine can cause a decrease in the absorption of Meclofenamic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Meclofenamic Acid
Cholestyramine can cause a decrease in the absorption of Meclofenamic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Medroxyprogesterone Acetate
The serum concentration of Medroxyprogesterone acetate can be decreased when it is combined with Cholestyramine.
Medrysone
Cholestyramine can cause a decrease in the absorption of Medrysone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Mefenamic Acid
Cholestyramine can cause a decrease in the absorption of Mefenamic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Megestrol Acetate
The serum concentration of Megestrol acetate can be decreased when it is combined with Cholestyramine.
Meloxicam
Cholestyramine can cause a decrease in the absorption of Meloxicam resulting in a reduced serum concentration and potentially a decrease in efficacy.
Mesalamine
Cholestyramine can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Mestranol
The serum concentration of Mestranol can be decreased when it is combined with Cholestyramine.
Methotrexate
Cholestyramine can cause a decrease in the absorption of Methotrexate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methyclothiazide
Cholestyramine can cause a decrease in the absorption of Methyclothiazide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methylprednisolone
Cholestyramine can cause a decrease in the absorption of Methylprednisolone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Metolazone
Cholestyramine can cause a decrease in the absorption of Metolazone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Minocycline
Cholestyramine can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Mometasone
Cholestyramine can cause a decrease in the absorption of Mometasone resulting in a reduced serum concentration and potentially a decrease in efficacy.
MYCOPHENOLATE
The serum concentration of Mycophenolic acid can be decreased when it is combined with Cholestyramine.
Mycophenolate Mofetil
Cholestyramine can cause a decrease in the absorption of Mycophenolate mofetil resulting in a reduced serum concentration and potentially a decrease in efficacy.
Mycophenolic Acid
The serum concentration of Mycophenolic acid can be decreased when it is combined with Cholestyramine.
Nabumetone
Cholestyramine can cause a decrease in the absorption of Nabumetone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Naftifine
Cholestyramine can cause a decrease in the absorption of Naftifine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Naproxen
Cholestyramine can cause a decrease in the absorption of Naproxen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nepafenac
Cholestyramine can cause a decrease in the absorption of Nepafenac resulting in a reduced serum concentration and potentially a decrease in efficacy.
Niacin
Cholestyramine can cause a decrease in the absorption of Niacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Niflumic Acid
Cholestyramine can cause a decrease in the absorption of Niflumic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nimesulide
Cholestyramine can cause a decrease in the absorption of Nimesulide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nomegestrol Acetate
The serum concentration of Nomegestrol acetate can be decreased when it is combined with Cholestyramine.
Norelgestromin
The serum concentration of Norelgestromin can be decreased when it is combined with Cholestyramine.
Norethindrone
The serum concentration of Norethisterone can be decreased when it is combined with Cholestyramine.
Norethynodrel
The serum concentration of Norethynodrel can be decreased when it is combined with Cholestyramine.
Norgestimate
The serum concentration of Norgestimate can be decreased when it is combined with Cholestyramine.
Norgestrel
The serum concentration of Norgestrel can be decreased when it is combined with Cholestyramine.
Oenothera biennis seed extract
Cholestyramine can cause a decrease in the absorption of Evening primrose oil resulting in a reduced serum concentration and potentially a decrease in efficacy.
Olopatadine
Cholestyramine can cause a decrease in the absorption of Olopatadine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Olsalazine
Cholestyramine can cause a decrease in the absorption of Olsalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ouabain
Cholestyramine can cause a decrease in the absorption of Ouabain resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ovine Digoxin Immune Fab
Cholestyramine can cause a decrease in the absorption of Digoxin Immune Fab (Ovine) resulting in a reduced serum concentration and potentially a decrease in efficacy.
Oxaprozin
Cholestyramine can cause a decrease in the absorption of Oxaprozin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Oxyphenbutazone
Cholestyramine can cause a decrease in the absorption of Oxyphenbutazone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Oxytetracycline
Cholestyramine can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Oxytetracycline Anhydrous
Cholestyramine can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Palmidrol
Cholestyramine can cause a decrease in the absorption of Palmidrol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Paramethasone
Cholestyramine can cause a decrease in the absorption of Paramethasone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Parecoxib
Cholestyramine can cause a decrease in the absorption of Parecoxib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Paricalcitol
The serum concentration of Paricalcitol can be decreased when it is combined with Cholestyramine.
Parthenolide
Cholestyramine can cause a decrease in the absorption of Parthenolide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Phenindione
Cholestyramine can cause a decrease in the absorption of Phenindione resulting in a reduced serum concentration and potentially a decrease in efficacy.
Phenobarbital
The serum concentration of Phenobarbital can be decreased when it is combined with Cholestyramine.
Phenprocoumon
Cholestyramine can cause a decrease in the absorption of Phenprocoumon resulting in a reduced serum concentration and potentially a decrease in efficacy.
Phenylbutazone
Cholestyramine can cause a decrease in the absorption of Phenylbutazone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pimecrolimus
Cholestyramine can cause a decrease in the absorption of Pimecrolimus resulting in a reduced serum concentration and potentially a decrease in efficacy.
Piretanide
Cholestyramine can cause a decrease in the absorption of Piretanide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pirfenidone
Cholestyramine can cause a decrease in the absorption of Pirfenidone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Piroxicam
Cholestyramine can cause a decrease in the absorption of Piroxicam resulting in a reduced serum concentration and potentially a decrease in efficacy.
Piroxicam-Beta-Cyclodextrin
Cholestyramine can cause a decrease in the absorption of Piroxicam resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pitavastatin
Cholestyramine can cause a decrease in the absorption of Pitavastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Polythiazide
Cholestyramine can cause a decrease in the absorption of Polythiazide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prasterone
Cholestyramine can cause a decrease in the absorption of Prasterone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pravastatin
Cholestyramine can cause a decrease in the absorption of Pravastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prednicarbate
Cholestyramine can cause a decrease in the absorption of Prednicarbate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prednisolone
Cholestyramine can cause a decrease in the absorption of Prednisolone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prednisone
Cholestyramine can cause a decrease in the absorption of Prednisone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pregnenolone
Cholestyramine can cause a decrease in the absorption of Pregnenolone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Propranolol
The serum concentration of Propranolol can be decreased when it is combined with Cholestyramine.
Proscillaridin
Cholestyramine can cause a decrease in the absorption of Proscillaridin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quinethazone
Cholestyramine can cause a decrease in the absorption of Quinethazone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Raloxifene
Cholestyramine can cause a decrease in the absorption of Raloxifene resulting in a reduced serum concentration and potentially a decrease in efficacy.
Resveratrol
Cholestyramine can cause a decrease in the absorption of Resveratrol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rimexolone
Cholestyramine can cause a decrease in the absorption of Rimexolone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rofecoxib
Cholestyramine can cause a decrease in the absorption of Rofecoxib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rosiglitazone
The serum concentration of Rosiglitazone can be decreased when it is combined with Cholestyramine.
Rosuvastatin
Cholestyramine can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Salicylamide
Cholestyramine can cause a decrease in the absorption of Salicylamide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Salicylic Acid
Cholestyramine can cause a decrease in the absorption of Salicylic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Salsalate
Cholestyramine can cause a decrease in the absorption of Salsalate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Serratiopeptidase
Cholestyramine can cause a decrease in the absorption of Serrapeptase resulting in a reduced serum concentration and potentially a decrease in efficacy.
Simvastatin
Cholestyramine can cause a decrease in the absorption of Simvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Spironolactone
The risk or severity of adverse effects can be increased when Cholestyramine is combined with Spironolactone.
Sulfasalazine
Cholestyramine can cause a decrease in the absorption of Sulfasalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sulindac
Cholestyramine can cause a decrease in the absorption of Sulindac resulting in a reduced serum concentration and potentially a decrease in efficacy.
Suprofen
Cholestyramine can cause a decrease in the absorption of Suprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tenoxicam
Cholestyramine can cause a decrease in the absorption of Tenoxicam resulting in a reduced serum concentration and potentially a decrease in efficacy.
Teriflunomide
The serum concentration of Teriflunomide can be decreased when it is combined with Cholestyramine.
Tetracycline
Cholestyramine can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Thyroid, Porcine
The serum concentration of Thyroid, porcine can be decreased when it is combined with Cholestyramine.
Tiaprofenic Acid
Cholestyramine can cause a decrease in the absorption of Tiaprofenic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tixocortol
Cholestyramine can cause a decrease in the absorption of Tixocortol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tolfenamic Acid
Cholestyramine can cause a decrease in the absorption of Tolfenamic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tolmetin
Cholestyramine can cause a decrease in the absorption of Tolmetin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Torsemide
Cholestyramine can cause a decrease in the absorption of Torasemide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tranilast
Cholestyramine can cause a decrease in the absorption of Tranilast resulting in a reduced serum concentration and potentially a decrease in efficacy.
Triamcinolone
Cholestyramine can cause a decrease in the absorption of Triamcinolone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tribenoside
Cholestyramine can cause a decrease in the absorption of Tribenoside resulting in a reduced serum concentration and potentially a decrease in efficacy.
Trichlormethiazide
Cholestyramine can cause a decrease in the absorption of Trichlormethiazide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ulipristal
The serum concentration of Ulipristal can be decreased when it is combined with Cholestyramine.
Ursodeoxycholate
The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Cholestyramine.
Ursodiol
The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Cholestyramine.
Valdecoxib
Cholestyramine can cause a decrease in the absorption of Valdecoxib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Vancomycin
The therapeutic efficacy of Vancomycin can be decreased when used in combination with Cholestyramine.
Warfarin
Cholestyramine can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zileuton
Cholestyramine can cause a decrease in the absorption of Zileuton resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zomepirac
Cholestyramine can cause a decrease in the absorption of Zomepirac resulting in a reduced serum concentration and potentially a decrease in efficacy.
